trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Breast Neoplasms D001943 24 associated lipids
Neoplasms D009369 13 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Yeh JR et al. AML1-ETO reprograms hematopoietic cell fate by downregulating scl expression. 2008 Development pmid:18156164
Seo JS et al. Cell cycle arrest and lytic induction of EBV-transformed B lymphoblastoid cells by a histone deacetylase inhibitor, Trichostatin A. 2008 Oncol. Rep. pmid:18097580
Carlisi D et al. Histone deacetylase inhibitors induce in human hepatoma HepG2 cells acetylation of p53 and histones in correlation with apoptotic effects. 2008 Int. J. Oncol. pmid:18097557
Zhang Y et al. Pro-IL-16 recruits histone deacetylase 3 to the Skp2 core promoter through interaction with transcription factor GABP. 2008 J. Immunol. pmid:18097041
Arany I et al. Restoration of CREB function ameliorates cisplatin cytotoxicity in renal tubular cells. 2008 Am. J. Physiol. Renal Physiol. pmid:18094030
Walton TJ et al. DNA demethylation and histone deacetylation inhibition co-operate to re-express estrogen receptor beta and induce apoptosis in prostate cancer cell-lines. 2008 Prostate pmid:18092350
Hajji N et al. Combinatorial action of the HDAC inhibitor trichostatin A and etoposide induces caspase-mediated AIF-dependent apoptotic cell death in non-small cell lung carcinoma cells. 2008 Oncogene pmid:18071312
Meng CF et al. Re-expression of methylation-induced tumor suppressor gene silencing is associated with the state of histone modification in gastric cancer cell lines. 2007 World J. Gastroenterol. pmid:18069755
Domingo-Domènech J et al. Inactivation of NF-kappaB by proteasome inhibition contributes to increased apoptosis induced by histone deacetylase inhibitors in human breast cancer cells. 2008 Breast Cancer Res. Treat. pmid:18064564
Seo H et al. Modulation of immunoglobulin gene conversion in chicken DT40 by enhancing histone acetylation, and its application to antibody engineering. 2007 Biotechnol. Genet. Eng. Rev. pmid:18059633
Sekhavat A et al. Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate. 2007 Biochem. Cell Biol. pmid:18059533
Sourlingas TG et al. Effect of the histone deacetylase inhibitor trichostatin a in human peripheral blood lymphocytes as a function of donor age. 2007 Ann. N. Y. Acad. Sci. pmid:18056955
Brest P et al. Histone deacetylase inhibitors promote the tumoricidal effect of HAMLET. 2007 Cancer Res. pmid:18056459
Schäfer S et al. Phenylalanine-containing hydroxamic acids as selective inhibitors of class IIb histone deacetylases (HDACs). 2008 Bioorg. Med. Chem. pmid:18054239
Susick L et al. Regulatory roles for histone deacetylation in IL-1beta-induced nitric oxide release in pancreatic beta-cells. 2008 Sep-Oct J. Cell. Mol. Med. pmid:18053091
Yoshida M [Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A]. 2007 Tanpakushitsu Kakusan Koso pmid:18051427
Shimazu T et al. [Biological diversity of protein lysine acetylation which has been revealed by small molecule inhibitors]. 2007 Tanpakushitsu Kakusan Koso pmid:18051411
Mazières J et al. Epigenetic regulation of RhoB loss of expression in lung cancer. 2007 BMC Cancer pmid:18047684
Khan AN et al. Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes and MHC class I antigen presentation by melanoma cells. 2008 Cancer Immunol. Immunother. pmid:18046553
Fenic I et al. In vivo application of histone deacetylase inhibitor trichostatin-a impairs murine male meiosis. 2008 Mar-Apr J. Androl. pmid:18046049
Wee G et al. Epigenetic alteration of the donor cells does not recapitulate the reprogramming of DNA methylation in cloned embryos. 2007 Reproduction pmid:18042635
Jin B et al. DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and immune function. 2008 Hum. Mol. Genet. pmid:18029387
Moiseeva EP et al. Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells. 2007 Mol. Cancer Ther. pmid:18025290
Park JJ et al. Functional interaction of the human cytomegalovirus IE2 protein with histone deacetylase 2 in infected human fibroblasts. 2007 J. Gen. Virol. pmid:18024889
Zhang L et al. Small molecule regulators of autophagy identified by an image-based high-throughput screen. 2007 Proc. Natl. Acad. Sci. U.S.A. pmid:18024584
Tanaka M et al. The Arabidopsis histone deacetylases HDA6 and HDA19 contribute to the repression of embryonic properties after germination. 2008 Plant Physiol. pmid:18024558
Malinen M et al. Distinct HDACs regulate the transcriptional response of human cyclin-dependent kinase inhibitor genes to Trichostatin A and 1alpha,25-dihydroxyvitamin D3. 2008 Nucleic Acids Res. pmid:17999998
Ramirez T et al. Sodium arsenite modulates histone acetylation, histone deacetylase activity and HMGN protein dynamics in human cells. 2008 Chromosoma pmid:17999076
Gan Y et al. Synergistic induction of apoptosis by HMG-CoA reductase inhibitor and histone deacetylases inhibitor in HeLa cells. 2008 Biochem. Biophys. Res. Commun. pmid:17996726
Renthal W et al. Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli. 2007 Neuron pmid:17988634
Honda H et al. Regulation of the CLDN3 gene in ovarian cancer cells. 2007 Cancer Biol. Ther. pmid:17986852
Stapnes C et al. Functional characteristics and gene expression profiles of primary acute myeloid leukaemia cells identify patient subgroups that differ in susceptibility to histone deacetylase inhibitors. 2007 Int. J. Oncol. pmid:17982680
Su RC et al. Epigenetic regulation of established human type 1 versus type 2 cytokine responses. 2008 J. Allergy Clin. Immunol. pmid:17980413
Putnik J et al. The interaction of ETV6 (TEL) and TIP60 requires a functional histone acetyltransferase domain in TIP60. 2007 Biochim. Biophys. Acta pmid:17980166
Shen L et al. Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters. 2007 PLoS Genet. pmid:17967063
Kim EJ et al. Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity. 2007 Mol. Cell pmid:17964266
Chen J et al. Cu2+ is required for pyrrolidine dithiocarbamate to inhibit histone acetylation and induce human leukemia cell apoptosis. 2008 Chem. Biol. Interact. pmid:17961528
Kuljaca S et al. Enhancing the anti-angiogenic action of histone deacetylase inhibitors. 2007 Mol. Cancer pmid:17958916
Oshima M et al. Molecular mechanism of transcriptional repression of AhR repressor involving ANKRA2, HDAC4, and HDAC5. 2007 Biochem. Biophys. Res. Commun. pmid:17949687
Schauber J et al. Histone acetylation in keratinocytes enables control of the expression of cathelicidin and CD14 by 1,25-dihydroxyvitamin D3. 2008 J. Invest. Dermatol. pmid:17943182
Carén H et al. Genetic and epigenetic changes in the common 1p36 deletion in neuroblastoma tumours. 2007 Br. J. Cancer pmid:17940511
Pourebrahim R et al. ZIC1 gene expression is controlled by DNA and histone methylation in mesenchymal proliferations. 2007 FEBS Lett. pmid:17936758
Pluemsampant S et al. Protein kinase CK2 is a key activator of histone deacetylase in hypoxia-associated tumors. 2008 Int. J. Cancer pmid:17935135
Itoh Y et al. Design, synthesis, structure--selectivity relationship, and effect on human cancer cells of a novel series of histone deacetylase 6-selective inhibitors. 2007 J. Med. Chem. pmid:17929798
Pulukuri SM et al. Inhibition of histone deacetylase activity promotes invasion of human cancer cells through activation of urokinase plasminogen activator. 2007 J. Biol. Chem. pmid:17923479
Qi J et al. [The role of secreted Wnt-antagonist genes hypermethylation in early detection of colorectal tumor]. 2007 Zhonghua Yi Xue Za Zhi pmid:17923031
Tao R et al. Deacetylase inhibition promotes the generation and function of regulatory T cells. 2007 Nat. Med. pmid:17922010
Li T and Chiang JY A novel role of transforming growth factor beta1 in transcriptional repression of human cholesterol 7alpha-hydroxylase gene. 2007 Gastroenterology pmid:17920062
Hämäläinen M et al. Inhibition of iNOS expression and NO production by anti-inflammatory steroids. Reversal by histone deacetylase inhibitors. 2008 Pulm Pharmacol Ther pmid:17913526
Noro R et al. PTEN inactivation in lung cancer cells and the effect of its recovery on treatment with epidermal growth factor receptor tyrosine kinase inhibitors. 2007 Int. J. Oncol. pmid:17912443
Zhang Y et al. An epigenetic modifier results in improved in vitro blastocyst production after somatic cell nuclear transfer. 2007 Cloning Stem Cells pmid:17907946
Lattal KM et al. Systemic or intrahippocampal delivery of histone deacetylase inhibitors facilitates fear extinction. 2007 Behav. Neurosci. pmid:17907845
Nishino N et al. Interaction of aliphatic cap group in inhibition of histone deacetylases by cyclic tetrapeptides. 2008 Bioorg. Med. Chem. pmid:17900911
Charrier C et al. Antiproliferative activities of a library of hybrids between indanones and HDAC inhibitor SAHA and MS-275 analogues. 2007 Bioorg. Med. Chem. Lett. pmid:17897824
Sichtig N et al. Papillomavirus binding factor binds to SAP30 and represses transcription via recruitment of the HDAC1 co-repressor complex. 2007 Arch. Biochem. Biophys. pmid:17897615
Schnur N et al. The histone deacetylase inhibitor trichostatin A mediates upregulation of 5-lipoxygenase promoter activity by recruitment of Sp1 to distinct GC-boxes. 2007 Biochim. Biophys. Acta pmid:17894944
Murga M et al. Global chromatin compaction limits the strength of the DNA damage response. 2007 J. Cell Biol. pmid:17893239
Akao Y et al. Downregulation of microRNAs-143 and -145 in B-cell malignancies. 2007 Cancer Sci. pmid:17892514
Wu P et al. [Role of human telomerase reverse transcriptase in apoptosis of human umbilical vein endothelial cells induced by trichostatin A]. 2007 Zhonghua Zhong Liu Za Zhi pmid:17892126
Pryzbylkowski P et al. Trichostatin A and 5 Aza-2' deoxycytidine decrease estrogen receptor mRNA stability in ER positive MCF7 cells through modulation of HuR. 2008 Breast Cancer Res. Treat. pmid:17891453
Zhao TC et al. Inhibition of histone deacetylases triggers pharmacologic preconditioning effects against myocardial ischemic injury. 2007 Cardiovasc. Res. pmid:17884027
Shivashimpi GM et al. Molecular design of histone deacetylase inhibitors by aromatic ring shifting in chlamydocin framework. 2007 Bioorg. Med. Chem. pmid:17881232
Ohoka N et al. Critical and functional regulation of CHOP (C/EBP homologous protein) through the N-terminal portion. 2007 J. Biol. Chem. pmid:17872950
Rao J et al. Trichostatin-A induces differential changes in histone protein dynamics and expression in HeLa cells. 2007 Biochem. Biophys. Res. Commun. pmid:17869223
Terry-Allison T et al. Relaxed repression of herpes simplex virus type 1 genomes in Murine trigeminal neurons. 2007 J. Virol. pmid:17855552
Chou SD and Tomasi TB Spatial distribution of histone methylation during MHC class II expression. 2008 Mol. Immunol. pmid:17850872
Kenneth NS et al. TRRAP and GCN5 are used by c-Myc to activate RNA polymerase III transcription. 2007 Proc. Natl. Acad. Sci. U.S.A. pmid:17848523
Wang F et al. Dynamic reprogramming of histone acetylation and methylation in the first cell cycle of cloned mouse embryos. 2007 Biol. Reprod. pmid:17823087
Ferreira R et al. Site-specific acetylation of ISWI by GCN5. 2007 BMC Mol. Biol. pmid:17760996
Manning J et al. Induction of MHC class I molecule cell surface expression and epigenetic activation of antigen-processing machinery components in a murine model for human papilloma virus 16-associated tumours. 2008 Immunology pmid:17725605
Campanero MR et al. The histone deacetylase inhibitor trichostatin A induces GADD45 gamma expression via Oct and NF-Y binding sites. 2008 Oncogene pmid:17724474
Zhang Y et al. Attenuated DNA damage repair by trichostatin A through BRCA1 suppression. 2007 Radiat. Res. pmid:17722998
Adcock IM et al. Epigenetic regulation of airway inflammation. 2007 Curr. Opin. Immunol. pmid:17720468
Frye M et al. Epidermal stem cells are defined by global histone modifications that are altered by Myc-induced differentiation. 2007 PLoS ONE pmid:17712411
Yasukawa K et al. Histone deacetylase inhibitors preferentially augment transient transgene expression in human dermal fibroblasts. 2007 Br. J. Dermatol. pmid:17711521
Tsaprouni LG et al. Suppression of lipopolysaccharide- and tumour necrosis factor-alpha-induced interleukin (IL)-8 expression by glucocorticoids involves changes in IL-8 promoter acetylation. 2007 Clin. Exp. Immunol. pmid:17711487
D'Alessio AC et al. Acetylation-induced transcription is required for active DNA demethylation in methylation-silenced genes. 2007 Mol. Cell. Biol. pmid:17709385
Chen WY et al. Histone deacetylase inhibitors reduce steroidogenesis through SCF-mediated ubiquitination and degradation of steroidogenic factor 1 (NR5A1). 2007 Mol. Cell. Biol. pmid:17709382
Robertson DM et al. Insulin-like Growth Factor Binding Protein-3 expression in the human corneal epithelium. 2007 Exp. Eye Res. pmid:17709104
Byers J and Eichinger D Acetylation of the Entamoeba histone H4 N-terminal domain is influenced by short-chain fatty acids that enter trophozoites in a pH-dependent manner. 2008 Int. J. Parasitol. pmid:17706222
Hong S et al. Differential regulation of thrombospondin-1 expression and antiangiogenesis of ECV304 cells by trichostatin A and helixor A. 2007 Anticancer Drugs pmid:17704650
Jamaluddin MD et al. Homocysteine inhibits endothelial cell growth via DNA hypomethylation of the cyclin A gene. 2007 Blood pmid:17698632
Ragno R et al. Class II-selective histone deacetylase inhibitors. Part 2: alignment-independent GRIND 3-D QSAR, homology and docking studies. 2008 Eur J Med Chem pmid:17698257
Zhou X et al. The interferon-alpha responsive gene TMEM7 suppresses cell proliferation and is downregulated in human hepatocellular carcinoma. 2007 Cancer Genet. Cytogenet. pmid:17693185
Sun DF et al. [The relationship of mTOR signaling pathway and histone acetylation in human gastric cancer cell lines]. 2007 Zhonghua Yi Xue Yi Chuan Xue Za Zhi pmid:17680526
Zhu K et al. Telomerase expression and cell proliferation in ovarian cancer cells induced by histone deacetylase inhibitors. 2008 Arch. Gynecol. Obstet. pmid:17680259
Tuncel M et al. The comparative effects of gene modulators on thyroid-specific genes and radioiodine uptake. 2007 Cancer Biother. Radiopharm. pmid:17679169
Wang J et al. Histone deacetylase inhibitors suppress TF-kappaB-dependent agonist-driven tissue factor expression in endothelial cells and monocytes. 2007 J. Biol. Chem. pmid:17675290
Tomita A et al. Epigenetic regulation of CD20 protein expression in a novel B-cell lymphoma cell line, RRBL1, established from a patient treated repeatedly with rituximab-containing chemotherapy. 2007 Int. J. Hematol. pmid:17675267
Gahr S et al. The combination of the histone-deacetylase inhibitor trichostatin A and gemcitabine induces inhibition of proliferation and increased apoptosis in pancreatic carcinoma cells. 2007 Int. J. Oncol. pmid:17671683
Cheli Y et al. Transcriptional and epigenetic regulation of the integrin collagen receptor locus ITGA1-PELO-ITGA2. 2007 Sep-Oct Biochim. Biophys. Acta pmid:17669516
Khaw AK et al. Inhibition of telomerase activity and human telomerase reverse transcriptase gene expression by histone deacetylase inhibitor in human brain cancer cells. 2007 Mutat. Res. pmid:17669439
El-Khoury V et al. The histone deacetylase inhibitor trichostatin A downregulates human MDR1 (ABCB1) gene expression by a transcription-dependent mechanism in a drug-resistant small cell lung carcinoma cell line model. 2007 Br. J. Cancer pmid:17667922
Huber LC et al. Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis. 2007 Arthritis Rheum. pmid:17665426
Wu Y et al. The zinc finger repressor, ZBP-89, recruits histone deacetylase 1 to repress vimentin gene expression. 2007 Genes Cells pmid:17663720
Li YL et al. [Impact of trichostatin A on gastric carcinoma cell line SGC-7901]. 2007 Zhonghua Wei Chang Wai Ke Za Zhi pmid:17659468
Nair S et al. Synergistic effects of a combination of dietary factors sulforaphane and (-) epigallocatechin-3-gallate in HT-29 AP-1 human colon carcinoma cells. 2008 Pharm. Res. pmid:17657594
Peng Y et al. The histone deacetylase inhibitor sodium butyrate inhibits baculovirus-mediated transgene expression in Sf9 cells. 2007 J. Biotechnol. pmid:17655959
Krämer OH et al. Histone deacetylase inhibitors and hydroxyurea modulate the cell cycle and cooperatively induce apoptosis. 2008 Oncogene pmid:17653085
Wang CT and Meng M [Experimental study on the effect of trichostatin A on differentiation of human lung carcinoma cell]. 2007 Zhonghua Yi Xue Za Zhi pmid:17650409